Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Kidney Neoplasms

abstract

  • Five prognostic factors for predicting survival were identified and used to categorize patients with metastatic RCC into three risk groups, for which the median survival times were separated by 6 months or more. These risk categories can be used in clinical trial design and interpretation and in patient management. The low long-term survival rate emphasizes the priority of clinical investigation to identify more effective therapy.

publication date

  • August 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10561319

Additional Document Info

start page

  • 2530

end page

  • 40

volume

  • 17

number

  • 8